Compare CYTK & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | WAY |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.7B |
| IPO Year | 2004 | 2024 |
| Metric | CYTK | WAY |
|---|---|---|
| Price | $62.41 | $34.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 15 |
| Target Price | ★ $82.38 | $46.53 |
| AVG Volume (30 Days) | ★ 2.2M | 1.8M |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $87,211,000.00 | ★ $1,039,842,000.00 |
| Revenue This Year | $346.43 | $16.69 |
| Revenue Next Year | $57.69 | $17.44 |
| P/E Ratio | ★ N/A | $55.47 |
| Revenue Growth | ★ 2609.26 | 14.76 |
| 52 Week Low | $29.31 | $29.40 |
| 52 Week High | $70.98 | $48.11 |
| Indicator | CYTK | WAY |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 56.02 |
| Support Level | $62.05 | $31.13 |
| Resistance Level | $66.59 | $33.72 |
| Average True Range (ATR) | 2.97 | 0.82 |
| MACD | 0.09 | 0.28 |
| Stochastic Oscillator | 33.47 | 98.45 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.